Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Designing the selenium and bladder cancer trial (SELEBLAT), a phase lll randomized chemoprevention study with selenium on recurrence of bladder cancer in Belgium ; volume:12 ; number:1 ; day:21 ; month:3 ; year:2012 ; pages:1-8 ; date:12.2012
BMC urology ; 12, Heft 1 (21.3.2012), 1-8, 12.2012
- Urheber
-
Goossens, Maria E.
- Beteiligte Personen und Organisationen
-
Buntinx, Frank
Joniau, Steven
Ackaert, Koen
Ameye, Filip
Billiet, Ignace
Braeckman, Johan
Breugelmans, Alex
Darras, Jochen
Dilen, Kurt
Goeman, Lieven
Kellen, Eliane
Tombal, Bertrand
Van Bruwaene, Siska
Van Cleyenbreuge, Ben
Van der Aa, Frank
Vekemans, Kris
Van Poppel, Hendrik
Zeegers, Maurice P.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2490-12-8
- URN
-
urn:nbn:de:1111-2016071624802
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:58 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Goossens, Maria E.
- Buntinx, Frank
- Joniau, Steven
- Ackaert, Koen
- Ameye, Filip
- Billiet, Ignace
- Braeckman, Johan
- Breugelmans, Alex
- Darras, Jochen
- Dilen, Kurt
- Goeman, Lieven
- Kellen, Eliane
- Tombal, Bertrand
- Van Bruwaene, Siska
- Van Cleyenbreuge, Ben
- Van der Aa, Frank
- Vekemans, Kris
- Van Poppel, Hendrik
- Zeegers, Maurice P.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Selenium and risk of bladder cancer
Selenium and cancer prevention
Bladder cancer
Selenium (Se) and breast cancer risk
Selenium speciation studies in cancer patients to evaluate the responses of biomarkers of selenium status to different selenium compounds
Treatment of bladder cancer
Selenium‐Doped Nanoheterojunctions for Highly Efficient Cancer Radiosensitization
Theranostic applications of selenium nanomedicines against lung cancer
Selenium and cancer risk in CHEK2 mutation carriers
New treatments in bladder cancer
Molecular markers in bladder cancer
Advances in bladder cancer imaging
Selenium and risk of bladder cancer
Selenium and cancer prevention
Bladder cancer
Selenium (Se) and breast cancer risk
Selenium speciation studies in cancer patients to evaluate the responses of biomarkers of selenium status to different selenium compounds
Treatment of bladder cancer
Selenium‐Doped Nanoheterojunctions for Highly Efficient Cancer Radiosensitization
Theranostic applications of selenium nanomedicines against lung cancer
Selenium and cancer risk in CHEK2 mutation carriers
New treatments in bladder cancer
Molecular markers in bladder cancer
Advances in bladder cancer imaging
Selenium and risk of bladder cancer
Selenium and cancer prevention
Bladder cancer
Selenium (Se) and breast cancer risk
Selenium speciation studies in cancer patients to evaluate the responses of biomarkers of selenium status to different selenium compounds
Treatment of bladder cancer
Selenium‐Doped Nanoheterojunctions for Highly Efficient Cancer Radiosensitization
Theranostic applications of selenium nanomedicines against lung cancer
Selenium and cancer risk in CHEK2 mutation carriers
New treatments in bladder cancer
Molecular markers in bladder cancer